Keyphrases
Systemic Lupus Erythematosus
92%
Lupus
64%
Peruvian
48%
Rheumatology
46%
Systemic Lupus Erythematosus Patient
45%
COVID-19
33%
Autoimmune Disease
30%
Rheumatic Diseases
29%
Health-related Quality of Life
27%
Systemic Lupus International Collaborating Clinics
24%
Latin America (LATAM)
24%
COVID-19 Vaccination
23%
Disease Activity
22%
Remission
21%
Confidence Interval
20%
Damage Accrual
20%
Peru
20%
Multi-ethnic
19%
American League
18%
Pan American
18%
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
18%
ANCA-associated Vasculitis
17%
Low Disease Activity
17%
COVID-19 Patients
17%
Living with
17%
Idiopathic Inflammatory Myopathies
17%
American College of Rheumatology
16%
Granulomatosis with Polyangiitis
16%
Latin American
16%
Systematic Literature Review
15%
Rheumatoid Arthritis
15%
Classification Criteria
14%
Microscopic Polyangiitis
14%
COVID-19 Outcomes
13%
Comorbidity
13%
European League against Rheumatism (EULAR)
12%
Clinical Features
12%
International Survey
12%
Age at Diagnosis
12%
Odds Ratio
11%
Frailty Index
11%
COVAD
11%
Zonulin
11%
Gut Permeability
11%
Inception Cohort
11%
Tertiary Care Hospital
11%
Patient Data
11%
Vasculitis
11%
SLE Disease Activity Index (SLEDAI)
11%
Long-term Safety
10%
Damage Index
10%
Takayasu Arteritis
9%
Healthy Controls
9%
Activity State
9%
Rheumatologists
9%
Patient Health
9%
Multivariable
9%
Autoimmune Rheumatic Diseases
8%
Health Disparities
8%
Prednisone
8%
United States
8%
Vaccine Hesitancy
8%
Disease Activity Score
8%
Disease Duration
8%
Non-genetic Factors
7%
Multivariable Model
7%
Hazard Ratio
7%
Population Interventions
7%
Giant Cell Arteritis
7%
SLICC
7%
Autoantibodies
7%
Lima
7%
Adverse Events
7%
Systemic Autoimmune Rheumatic Diseases
6%
Epidemiology
6%
Brazil
6%
Environmental Factors
6%
Rheumatoid Arthritis Patients
6%
Hospitalization
6%
Symptom Duration
6%
Coronavirus Disease 2019 Vaccination
6%
Latin American Patient
6%
Long COVID-19
6%
Physical Activity
6%
Health Care Use
6%
Access to Care
6%
Disease Flare
6%
Polymyalgia Rheumatica
5%
General Practitioners
5%
Comparative Analysis
5%
COVID-19 Pandemic
5%
Oxygenation
5%
Demographic Characteristics
5%
COVID-19 Breakthrough Infections
5%
COVID Vaccination
5%
Epidemiologic Profile
5%
Referral Center
5%
Systemic Vasculitis
5%
IgG4-related Disease (IgG4-RD)
5%
Global Excellence
5%
Medicine and Dentistry
Systemic Lupus Erythematosus
100%
Lupus Erythematosus
64%
Rheumatology
54%
COVID-19
48%
Rheumatic Disease
35%
Disease Activity
34%
ANCA Associated Vasculitis
29%
Rheumatoid Arthritis
18%
Vasculitis
16%
Granulomatosis with Polyangiitis
16%
Autoimmune Disease
16%
Disease
16%
Autoimmune Rheumatic Disease
15%
Cross Sectional Study
14%
Quality of Life
14%
Microscopic Polyangiitis
13%
Clinical Feature
12%
Frailty
11%
Myositis
11%
COVID-19 Vaccination
11%
Vaccine Hesitancy
11%
SLEDAI
10%
Symptom
10%
Systematic Review
9%
Takayasu's Arteritis
9%
Prevalence
9%
Health Care Cost
8%
Disease Exacerbation
8%
Disease Duration
8%
Glucocorticoid
8%
Patient Referral
7%
Infection
7%
Hazard Ratio
7%
Prednisone
7%
Immunosuppressant
7%
Health Disparity
6%
Giant-Cell Arteritis
6%
COVID-19 Vaccine
6%
Cohort Effect
6%
Odds Ratio
6%
Physical Activity
6%
Personal Experience
6%
Hand-Schüller-Christian Disease
6%
Adverse Event
5%
Acute Respiratory Distress Syndrome
5%
Booster Dose
5%
Herd Immunity
5%
Clinimetrics
5%
Evans Syndrome
5%
Hemolytic Anemia
5%
Metabolic Syndrome
5%
Low and Middle Income Countries
5%
Exercise
5%
Gut
5%
Patient-Data
5%
Zonulin
5%
IgG4-Related Disease
5%
Medicine
5%
Immunomodulation
5%
Tertiary Care
5%
Self Concept
5%
Health Care
5%
Cardiovascular Risk
5%
Systemic Vasculitis
5%
Observational Study
5%
Mental Capacity
5%
Insulin Dependent Diabetes Mellitus
5%
Type 1 Diabetes
5%
Antiphospholipid Antibody
5%
Cognitive Defect
5%
Photosensitivity
5%
Lean Body Weight
5%
Drug Therapy
5%
Medical Record
5%